15-89175964-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_152924.5(ABHD2):c.691G>A(p.Val231Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000174 in 1,612,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152924.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABHD2 | NM_152924.5 | c.691G>A | p.Val231Ile | missense_variant | Exon 6 of 11 | ENST00000352732.10 | NP_690888.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABHD2 | ENST00000352732.10 | c.691G>A | p.Val231Ile | missense_variant | Exon 6 of 11 | 1 | NM_152924.5 | ENSP00000268129.5 | ||
ABHD2 | ENST00000565973.5 | c.691G>A | p.Val231Ile | missense_variant | Exon 10 of 15 | 5 | ENSP00000455639.1 | |||
ABHD2 | ENST00000562073.1 | n.515G>A | non_coding_transcript_exon_variant | Exon 4 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250478Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135410
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460256Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 726208
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.691G>A (p.V231I) alteration is located in exon 10 (coding exon 4) of the ABHD2 gene. This alteration results from a G to A substitution at nucleotide position 691, causing the valine (V) at amino acid position 231 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at